- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ACZ885 150 mg (Canakinumab)
Total 2194 results
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisJapan
-
Novartis PharmaceuticalsCompletedAcute GoutUnited States, Canada, Russian Federation, Netherlands, China
-
PfizerCompletedDiabetes Melliuts, Type 2United States
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Italy, United Kingdom, Netherlands, Canada, Germany, Australia, Spain, Switzerland, France
-
Rigel PharmaceuticalsCompletedIGA NephropathyUnited States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
-
Warner ChilcottCompletedPostmenopausal OsteoporosisUnited States
-
Georgetown UniversityUnknown
-
Bill & Melinda Gates Medical Research InstituteNot yet recruitingHealthy VolunteersKenya, Uganda
-
Bausch Health Americas, Inc.Completed
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, South Africa, United States, Russian Federation, France, Slovakia, Spain, Thailand, Czechia, Greece, Argentina, Peru, United Kingdom, Bulgaria, Turkey, Hungary, Vietnam, Philippines, Colombia, Chile
-
Yuhan CorporationActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Taiwan, Serbia, Singapore, Thailand, Philippines, Turkey, Malaysia, Russian Federation, Greece, Ukraine
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
AstraZenecaCompletedMajor Depressive DisorderUnited Kingdom
-
Merck Sharp & Dohme LLCCompletedHuman Immunodeficiency Virus-1 (HIV-1)
-
Reata, a wholly owned subsidiary of BiogenAbbVie; Friedreich's Ataxia Research AllianceActive, not recruitingFriedreich AtaxiaUnited States, Australia, Austria, Italy, United Kingdom
-
NovartisCompletedType 2 Diabetes Mellitus | Impaired Glucose ToleranceUnited States, Canada, Finland, Australia, Germany, India, Italy
-
Rigel PharmaceuticalsWithdrawn
-
Novartis PharmaceuticalsTerminatedGouty ArthritisChina, Poland, Singapore, Argentina
-
NovartisCompletedHypertensionSlovakia, Italy, Netherlands, Argentina, Germany, Poland, Czech Republic, Iceland
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
CephalonCompletedChronic Shift Work Sleep DisorderUnited States
-
Novartis PharmaceuticalsCompletedAcute GoutColombia, Switzerland, Germany, Russian Federation, Singapore, Australia, Belgium, Canada, Estonia, Guatemala, Latvia, Lithuania, Mexico, Norway, Poland, Sweden, Ukraine
-
Janssen Research & Development, LLCCompleted
-
Taiwan Liposome CompanyCompletedOsteoarthritis of the KneeTaiwan, Australia
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Eisai Inc.Active, not recruitingBreast Neoplasms | Receptors, Estrogen | Genes, Erbb-2United States, United Kingdom
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorGermany, Netherlands
-
Vanderbilt University Medical CenterCompletedHigh Blood PressureUnited States
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Novartis PharmaceuticalsCompletedOsteoarthritisUnited States, Germany, Finland, France
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsCompletedAnklyosing SpondylitisGermany, Austria, Spain, Switzerland, United Kingdom, United States, Singapore, Russian Federation, Netherlands, Italy, Finland, Czechia, Canada
-
Corcept TherapeuticsCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.RecruitingAdvanced Basal Cell CarcinomaUnited States
-
Amicus TherapeuticsRecruitingFabry DiseaseSpain, United States, Japan, Australia, France, Portugal
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLocally Advanced Rectal CancerUnited States, Spain
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Belgium, Hungary, Turkey, Guatemala, Slovakia, Germany, Puerto Rico, Poland
-
Novartis PharmaceuticalsRecruitingNon-Small Cell Lung CarcinomaIndia
-
BayerCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedFatigueUnited States
-
Fondazione OncotechNot yet recruiting
-
EMD SeronoTerminatedLupus Erythematosus, SystemicUnited States, Korea, Republic of, Bulgaria, Argentina, Mexico, Italy, Spain, Philippines, Germany, Czechia, Chile, Poland, Peru, United Kingdom, South Africa, Brazil, Russian Federation
-
Janssen R&D IrelandCompleted
-
Corcept TherapeuticsCompleted
-
Samsung Medical CenterCompletedStomach NeoplasmsKorea, Republic of
-
Axsome Therapeutics, Inc.CompletedObstructive Sleep Apnea | Narcolepsy | Postpartum | Excessive Sleepiness | Excessive Daytime SomnolenceUnited States
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.CompletedNonalcoholic Steatohepatitis (NASH)China
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada